Prokidney (PROK) Asset Utilization Ratio (2024 - 2026)

Prokidney's (PROK) quarterly Asset Utilization Ratio came in at 0.0 in Q1 2026, up 291.67% year-on-year from 0.0 in Q1 2025, and up 8.87% on a QoQ basis from 0.0 in Q4 2025.

Prokidney (PROK) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

Prokidney (PROK) has 3 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio rose 291.67% year-over-year to 0.0 in Q1 2026; TTM through Mar 2026 was 0.0, a 291.67% increase from a year earlier, with the FY2025 full-year figure at 0.0, up 1203.56% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.0, up from 0.0 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for PROK reached as high as 0.0 in Q1 2026 and fell as low as 0.0 in Q4 2024.
  • Historically, Asset Utilization Ratio has averaged 0.0 across 3 years, with a median of 0.0 in 2025.
  • Across the five-year window, Asset Utilization Ratio soared 1466.02% in 2025 and surged 291.67% in 2026, its largest moves.
  • Year by year, Asset Utilization Ratio stood at 0.0 in 2024, then surged by 1466.02% to 0.0 in 2025, then advanced by 8.87% to 0.0 in 2026.
  • Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.0 in Q1 2026, 0.0 in Q4 2025, and 0.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 0.69
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 0.37
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Prokidney 96.00 Mn 96.00 Mn - 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00